Pharmacogenomic analysis of patientderived tumor cells in gynecologic cancers
Pharmacogenomic analysis of patientderived tumor cells in gynecologic cancers
Gynecologic malignancy is one of the leading causes of mortality in female adults worldwide. Comprehensive genomic analysis has revealed a list of molecular aberrations that are essential to tumorigenesis, progression, and metastasis of gynecologic tumors.